Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730338 · ClinicalTrials.gov registry record · NA
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
A NA study of Metastatic Prostate Cancer, sponsored by Movember Foundation.
- Active
- Registry status
- NA
- Development phase
- 866
- Enrollment target
- 18
- Study locations
NCT02730338: Active NA study of Metastatic Prostate Cancer, sponsored by Movember Foundation.
NCT02730338 is a NA study of Metastatic Prostate Cancer that is active but no longer recruiting, run by Movember Foundation. The registered enrollment target is 866 participants, above the 165-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (425% higher). The trial reports 18 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02730338, a NA study of Metastatic Prostate Cancer, is active but no longer recruiting, sponsored by Movember Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 866 participants
- Enrollment target
- 18
- Study locations
Study Summary
To determine if supervised high intensity aerobic and resistance training increases overall survival compared to self-directed exercise in patients with metastatic prostate cancer.
Primary Outcome
Overall survival will be measured from the time of randomization until death
Conditions Studied
Interventions
- BEHAVIORAL High intensity aerobic and resistance training
- BEHAVIORAL Psychosocial support
Study Locations (18)
Other
- Centre Hospitalier de l'Université de Montréal (CRCHUM) - Montreal
- German Sport University Cologne - Cologne
- Erasmus MC - Rotterdam
- Queen's University Belfast - Belfast
- University of Glasgow - Glasgow
- Kings College London - London
California
- Cedars Sinai Medical Centre - Los Angeles
- UCSF - San Francisco
Queensland
- Australian Prostate Cncr Research Centre - Brisbane
- University of Queensland - Brisbane
Colorado
- UC Denver - Denver
Minnesota
- University of Minnesota - Minneapolis
Oregon
- Oregon Health & Science University - Portland
Washington
- Fred Hutchinson Cancer Centre - Seattle
Victoria
- Victoria University / Sunshine Hospital - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 866 participants |
| Start Date | 2016-01 |
| Est. Completion | 2026-10 |
| Phase | NA |
What the registry record for NCT02730338 still lists
NCT02730338 is an interventional study that assigns participants to a tested intervention. The registered 866 participants enrollment target is mid-sized for trials with a published cap, above the 165-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (425% higher).
The record links to 1 condition, with Metastatic Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which High intensity aerobic and resistance training is the first listed.
NCT02730338 lists 18 locations in 11 states (Other, California, Queensland).
Frequently Asked Questions
What is clinical trial NCT02730338 about?
NCT02730338 is a clinical study titled "INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)". To determine if supervised high intensity aerobic and resistance training increases overall survival compared to self-directed exercise in patients with metastatic prostate cancer.
What is the current status of trial NCT02730338?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 866 participants. The study started on 2016-01. Estimated completion is 2026-10.
What conditions does trial NCT02730338 study?
This clinical trial studies the following conditions: Metastatic Prostate Cancer.
What interventions are being tested in trial NCT02730338?
The interventions under investigation include: High intensity aerobic and resistance training (BEHAVIORAL), Psychosocial support (BEHAVIORAL).
Who is sponsoring clinical trial NCT02730338?
This trial is sponsored by Movember Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02730338 being conducted?
This trial has 18 study locations across California, Colorado, Minnesota, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02730338's enrollment target sits among peer trials
866 3rd of 41 higher than 39 of 41 other Metastatic Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
RECRUITING · NA
-
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
RECRUITING · NA
-
7-Days Water-Only Fasting Trial in Prostate Cancer
RECRUITING · NA
-
Physician- and Patient-based Barriers to NGS Testing
RECRUITING · NA
-
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)
RECRUITING · NA
-
Study of AZD0754 in Participants With Metastatic Prostate Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- NCT05369052 · 865 participants · Phase 3
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT06256588 · 864 participants · Phase 3
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia